Centre in Talks with Pune Drugmaker Gennova Biopharma to Test mRNA Vaccine for Booster Dose

Days, after India announced “precaution dose” for healthcare, frontline workers and 60+ population with comorbidities, the government at the Centre is said to be in discussion with Pune-based Gennova Biopharmaceuticals to consider its mRNA vaccine for booster dose, said a report. Gennova’s Messenger RNA or mRNA vaccine is in the late-stage trial where it has already completed phase 2 studies and has progressed well in the third phase.Also Read – How COVID 'Precautionary Doses' Are Different From Booster Shots? Vaccine Panel Chief Explains

Leave a Reply